Search for: "Ayerst Laboratories Inc" Results 21 - 40 of 47
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jul 2010, 2:39 pm by Bexis
Abbott Laboratories, 607 P.2d 924 (Cal. 1980), a DES case. [read post]
6 Jul 2007, 4:29 am
Ayerst Laboratories, 548 A.2d 798, 802 n.6 (D.C. 1988). [read post]
2 Sep 2009, 11:22 pm
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004), and Desiano v. [read post]
3 Mar 2012, 5:36 pm by Schachtman
Wyeth-Ayerst Laboratories Co., appears to recognize that risk and cause are distinct concepts. 278 F. [read post]
12 Mar 2024, 12:46 pm by admin
Wyeth-Ayerst Laboratories Co., 278 F.Supp.2d 684, 700 (W.D.N.C. 2003) (expert witnesses may not opine about corporate intent and motive) (barring Dr. [read post]
5 Jun 2013, 5:29 am by Schachtman
Merrill-National Laboratories, 646 F.Supp. 856 (D. [read post]
14 Mar 2008, 6:07 am
Wyeth-Ayerst Laboratories Co., the court encountered the redoubtable (we would say, very doubtable) Dr. [read post]
27 Aug 2010, 2:41 pm by Bexis
Ayerst Laboratories, Inc., 607 P.2d 1339, 1349-50 (Kan. [read post]
28 Jun 2007, 10:16 am
Wyeth-Ayerst Laboratories, 283 F.3d 315, 321 (5th Cir. 2002), and Williams v. [read post]
18 Mar 2011, 10:04 am by Schachtman
Wyeth-Ayerst Laboratories Co., appears to recognize that risk and cause are distinct concepts. 278 F. [read post]
3 Jun 2010, 1:37 pm by Bexis
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004); White v. [read post]
19 Mar 2022, 2:09 pm by admin
”[4] The United States Environmental Protection Agency (EPA) acknowledges that estimating “risk” from low level exposures based upon laboratory animal data is fraught because of inter-specie differences in longevity, body habitus and size, genetics, metabolism, excretion patterns, genetic homogeneity of laboratory animals, dosing levels and regimens. [read post]